BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This advanced responsive optical formulation features Nile red labeled thermosensitive liposomes. The structural framework utilizes a phase-transition lipid base composed primarily of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) designed to undergo a sharp gel-to-liquid-crystalline phase transition at a specific thermal threshold (41ºC), incorporating the solvatochromic hydrophobic probe Nile red directly within the hydrocarbon tail core. This specific design causes the fluorescence emission intensity and wavelength shift of the probe to become exceptionally sensitive to the sudden alteration in membrane polarity and fluidity when passing through the phase boundary, creating an established baseline standard for tracking thermal lipid melting kinetics.
Source
Custom synthesis
Functional Group
Nile red; Thermosensitive lipid matrix
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.